Cargando…
Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
INTRODUCTION: Uterine serous carcinoma (USC) is more aggressive than other subtypes of endometrial carcinoma and is associated with a poor prognosis. We analyzed the metabolomic profile of USC with acquired resistance to paclitaxel. RESULTS: Glutathione (GSH) concentration in PTX-1 cells was higher...
Autores principales: | Seino, Manabu, Ohta, Tsuyoshi, Sugiyama, Akiko, Sakaki, Hirotsugu, Sudo, Takeshi, Tsutsumi, Seiji, Shigeta, Shogo, Tokunaga, Hideki, Toyoshima, Masafumi, Yaegashi, Nobuo, Nagase, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112827/ https://www.ncbi.nlm.nih.gov/pubmed/30174791 http://dx.doi.org/10.18632/oncotarget.25868 |
Ejemplares similares
-
Correction: Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel
por: Seino, Manabu, et al.
Publicado: (2021) -
Successful management of cutaneous lymphangitis carcinomatosa arising from cervical cancer with paclitaxel-cisplatin and bevacizumab combination therapy: a case report and review of the literature
por: Nakamura, Fumihiro, et al.
Publicado: (2019) -
xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma
por: Sugiyama, Akiko, et al.
Publicado: (2020) -
Tumor lysis syndrome associated with docetaxel and carboplatin in a case with recurrent endometrial cancer
por: Ito, Tomomichi, et al.
Publicado: (2018) -
Squamous cell carcinoma arising from a mature cystic teratoma of the ovary: Successful treatment with carboplatin, paclitaxel, and bevacizumab
por: Fukase, Mika, et al.
Publicado: (2020)